Oculis Holding AG (OCS) stock, explained like you're 5

Is Oculis Holding AG a small, medium or large cap company?

No. Oculis Holding AG is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 514 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Oculis Holding AG makes money

• Selling medicines, medical devices or healthcare services.
• Insurance premiums or hospital and clinic fees.
• Research and licensing deals.

What moves OCS stock

• Results from clinical trials and approvals from regulators.
• Drug prices, insurance rules and government policy.
• Patents running out and new competing treatments.

In the news lately

• Oculis Holding AG (CR5.SG) Stock Price, News, Quote & History (Yahoo! Finance Canada)
• (OCS) Risk Channels and Responsive Allocation (Stock Traders Daily)
• Oculis Holding (NasdaqGM:OCS) Stock Forecast & Analyst Predictions (Simply Wall Street)
• Oculis Holding AG Stock 12‑Month Price Target Cut to $36.33, Implies 317% Upside (TradingView)
• Trial results for a potential dry eye drug are on track for around year end, Oculis says. (Stock Titan)

Key terms to know before you follow OCS

• Market cap
• P/E ratio
• EPS (earnings per share)
• Earnings report
• Volatility